Shashwat Mishra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shashwat Mishra has a total of 166 co-authors. Here are the top co-authors by number of shared publications:
Kanwaljeet Garg
Department of Neurosurgery & Gamma-Knife, All India Institute of Medical Sciences, New Delhi, India
8 shared publications- Kanwaljeet Garg
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, Delhi, India
6 shared publications Manmohan Singh
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India
5 shared publications- Raghav Singla
Department of Neurosurgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India
5 shared publications Pankaj Kumar Singh
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India
4 shared publicationsRavi Sharma
Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India
4 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Springer Nature in Discover Neuroscience
- Vol. 21 (1) , 113
Clinicopathologic spectrum and diagnostic insights from IgG4-related disease of the CNS
- 17 October 2026
- Published by Springer Nature in Discover Neuroscience
- Vol. 21 (1) , 113
Open AccessClinicopathologic spectrum and diagnostic insights from IgG4-related disease of the CNS
- 4 January 2024
- Published by Elsevier in World Neurosurgery
- Vol. 183, e512-e521
Neurosurgery as a Top-Drawer Choice for Residency in India: Reality or Myth?
- 4 January 2024
- Published by Elsevier in World Neurosurgery
- Vol. 183, e512-e521
Neurosurgery as a Top-Drawer Choice for Residency in India: Reality or Myth?
- 1 January 2023
- Published by Medknow in Neurology India
- Vol. 71 (2) , 238-242
Posterior C1–C2 Fusion in an Unstable Type II Odontoid Fracture: Steps of Ganglion Preservation/Preganglionic Sectioning
Neurol India is an peer-reviewed biomedical periodical of Neurological Society of India.
- 1 January 2023
- Published by Medknow in Neurology India
- Vol. 71 (2) , 238-242
Posterior C1–C2 Fusion in an Unstable Type II Odontoid Fracture: Steps of Ganglion Preservation/Preganglionic Sectioning
Neurol India is an peer-reviewed biomedical periodical of Neurological Society of India.
- Open Access
- 27 December 2022
- Published by Georg Thieme Verlag KG in Indian Journal of Neurotrauma
- Vol. 20 (02) , 140-147
Technical Considerations in Surgical Fixation of Jefferson Fracture
Jefferson fracture is defined as the simultaneous disruption of the continuity of the anterior and posterior arches of the atlas vertebra. It generally results from an axial impact to the head. Most of these fractures are amenable to nonoperative management. Significant disruption of the transverse atlantal ligament that is the main stabilizing ligament of the atlantoaxial articulation and contiguous spinal injuries often form the indications for operative intervention in these fractures. The outward and caudal displacement of the C1 lateral masses observed in these fractures often requires significant deviation from the standard operative technique of atlantoaxial fixation when the osseous elements are intact. Accordingly, we have described the surgical nuances relevant to the exposure and instrumentation of the atlantoaxial region in the setting of Jefferson fracture, through our experience in two cases.
- 27 December 2022
- Published by Georg Thieme Verlag KG in Indian Journal of Neurotrauma
- Vol. 20 (02) , 140-147
Open AccessTechnical Considerations in Surgical Fixation of Jefferson Fracture
Jefferson fracture is defined as the simultaneous disruption of the continuity of the anterior and posterior arches of the atlas vertebra. It generally results from an axial impact to the head. Most of these fractures are amenable to nonoperative management. Significant disruption of the transverse atlantal ligament that is the main stabilizing ligament of the atlantoaxial articulation and contiguous spinal injuries often form the indications for operative intervention in these fractures. The outward and caudal displacement of the C1 lateral masses observed in these fractures often requires significant deviation from the standard operative technique of atlantoaxial fixation when the osseous elements are intact. Accordingly, we have described the surgical nuances relevant to the exposure and instrumentation of the atlantoaxial region in the setting of Jefferson fracture, through our experience in two cases.
- 1 September 2022
- Published by Medknow in Neurology India
- Vol. 70 (Suppl 2) , S166-S174
AIIMS Cervical Myelopathy Score – A New Comprehensive and Objective Patient-Reported Modification of mJOA
Background: Several scoring systems have been developed for assessment of patients with compressive cervical myelopathy. However, all of these have some shortcomings. We proposed a new modification of the modified Japanese Orthopedic Association (mJOA) score—the AIIMS cervical myelopathy score (ACMS).Objective: The aim of this study was to compare the ACMS with mJOA score and Nurick score.Methods: We prospectively studied patients with cervical compressive myelopathy. The new ACMS, mJOA, Nurick proposed by Benzel, and Nurick scores were recorded preoperatively and at three months postoperatively in patients.Results: Sixty-two patients completed the 3-month follow-up and were included in the final analysis. The mean preoperative and postoperative Nurick, mJOA, and ACMS scores were 3.3 and 3.0, 12.3 and 13.8, and 15.1 and 17.7, respectively. High correlation (Pearson'sr> 0.8, 95% CI: 0.94 to 0.97,P< 0.005) was observed between ACMS and mJOA scores for all the individual components of both scales, both in pre- and postoperative assessments. A negative correlation was observed between the occupational ability scores ACMS and the Nurick scale (r= −0.76, 95% CI: −0.83 to − 0.68). No correlation was found with cord/canal ratio on magnetic resonance imaging (MRI) with any of the three scoring systems (preoperative, postoperative, or recovery rates).Conclusions: The ACMS score showed a good correlation with the mJOA score for evaluation of functional disability in the setting of cervical myelopathy. The patients could themselves report the scores using the ACMS scoring chart. The occupational component of the ACMS also correlated well with the Nurick score.
- 1 September 2022
- Published by Medknow in Neurology India
- Vol. 70 (Suppl 2) , S166-S174
AIIMS Cervical Myelopathy Score – A New Comprehensive and Objective Patient-Reported Modification of mJOA
Background: Several scoring systems have been developed for assessment of patients with compressive cervical myelopathy. However, all of these have some shortcomings. We proposed a new modification of the modified Japanese Orthopedic Association (mJOA) score—the AIIMS cervical myelopathy score (ACMS).Objective: The aim of this study was to compare the ACMS with mJOA score and Nurick score.Methods: We prospectively studied patients with cervical compressive myelopathy. The new ACMS, mJOA, Nurick proposed by Benzel, and Nurick scores were recorded preoperatively and at three months postoperatively in patients.Results: Sixty-two patients completed the 3-month follow-up and were included in the final analysis. The mean preoperative and postoperative Nurick, mJOA, and ACMS scores were 3.3 and 3.0, 12.3 and 13.8, and 15.1 and 17.7, respectively. High correlation (Pearson'sr> 0.8, 95% CI: 0.94 to 0.97,P< 0.005) was observed between ACMS and mJOA scores for all the individual components of both scales, both in pre- and postoperative assessments. A negative correlation was observed between the occupational ability scores ACMS and the Nurick scale (r= −0.76, 95% CI: −0.83 to − 0.68). No correlation was found with cord/canal ratio on magnetic resonance imaging (MRI) with any of the three scoring systems (preoperative, postoperative, or recovery rates).Conclusions: The ACMS score showed a good correlation with the mJOA score for evaluation of functional disability in the setting of cervical myelopathy. The patients could themselves report the scores using the ACMS scoring chart. The occupational component of the ACMS also correlated well with the Nurick score.
- 25 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 165, e59-e73
Managing Traumatic Brain Injury During the Coronavirus Disease 2019 Pandemic–A Case-Matched Controlled Analysis of Immediate Outcomes
- 25 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 165, e59-e73
Managing Traumatic Brain Injury During the Coronavirus Disease 2019 Pandemic–A Case-Matched Controlled Analysis of Immediate Outcomes
- 26 February 2022
- Published by Springer Nature in Head and Neck Pathology
- Vol. 16 (3) , 728-737
Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions
Benign fibro-osseous lesions (BFOLs) are a diverse group of lesions showing considerable degree of overlap with low grade osteosarcoma (LGOS). Further, de-differentiated osteosarcoma (DOS) is usually indistinguishable from conventional high-grade OS (COS) if LGOS foci are not identified. Thus, there is a need for adjunctive immunohistochemical markers to differentiate OS from benign FOLs as well as DOS from COS. This study evaluated the role of immunohistochemical expression of MDM2, CDK4, parafibromin, BCL-2 and Galectin-1 (Gal-1) in accurate characterization of benign FOLs and in differentiating them from OS. From our archives, we retrieved 101 tissue samples which were diagnosed as osteosarcoma (OS) /ossifying fibroma (OF) / fibrous dysplasia (FD) or fibrous hyperplasia (FH) and examined their immunohistochemical staining pattern with the aforementioned antibodies. MDM2 showed 100% specificity for diagnosing OS. CDK4 and Gal-1 showed linear increase in immunoexpression from benign BFOLs to OS. BCL-2 showed equivocal immunopositivity in OF and OS, but the positivity was higher than that observed in FD. The highest immunoexpression for parafibromin was seen in FD followed by OF and OS cases. Thus, MDM2 is most specific, and Gal-1 is most sensitive of all the markers studied in differentiating OS from benign mimics. Combination of these two markers can be used as an adjunct to conventional imaging and microscopy in accurate characterization of these lesions. Further MDM2 overexpression can differentiate DOS and COS.
- 26 February 2022
- Published by Springer Nature in Head and Neck Pathology
- Vol. 16 (3) , 728-737
Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions
Benign fibro-osseous lesions (BFOLs) are a diverse group of lesions showing considerable degree of overlap with low grade osteosarcoma (LGOS). Further, de-differentiated osteosarcoma (DOS) is usually indistinguishable from conventional high-grade OS (COS) if LGOS foci are not identified. Thus, there is a need for adjunctive immunohistochemical markers to differentiate OS from benign FOLs as well as DOS from COS. This study evaluated the role of immunohistochemical expression of MDM2, CDK4, parafibromin, BCL-2 and Galectin-1 (Gal-1) in accurate characterization of benign FOLs and in differentiating them from OS. From our archives, we retrieved 101 tissue samples which were diagnosed as osteosarcoma (OS) /ossifying fibroma (OF) / fibrous dysplasia (FD) or fibrous hyperplasia (FH) and examined their immunohistochemical staining pattern with the aforementioned antibodies. MDM2 showed 100% specificity for diagnosing OS. CDK4 and Gal-1 showed linear increase in immunoexpression from benign BFOLs to OS. BCL-2 showed equivocal immunopositivity in OF and OS, but the positivity was higher than that observed in FD. The highest immunoexpression for parafibromin was seen in FD followed by OF and OS cases. Thus, MDM2 is most specific, and Gal-1 is most sensitive of all the markers studied in differentiating OS from benign mimics. Combination of these two markers can be used as an adjunct to conventional imaging and microscopy in accurate characterization of these lesions. Further MDM2 overexpression can differentiate DOS and COS.
- 14 February 2022
- Published by Elsevier in World Neurosurgery
- Vol. 161, 136-146
Telementoring Feasibility Using a Novel Low-cost Lazy Glass Microsurgical Simulator: A “Proof of Concept” Experimental Study
- 14 February 2022
- Published by Elsevier in World Neurosurgery
- Vol. 161, 136-146
Telementoring Feasibility Using a Novel Low-cost Lazy Glass Microsurgical Simulator: A “Proof of Concept” Experimental Study
- 10 February 2022
- Published by Elsevier in World Neurosurgery
- Vol. 161, 54
Superficial Temporal Artery to Middle Cerebral Artery Bypass for Moyamoya Disease: Surgical Nuances
- 10 February 2022
- Published by Elsevier in World Neurosurgery
- Vol. 161, 54
Superficial Temporal Artery to Middle Cerebral Artery Bypass for Moyamoya Disease: Surgical Nuances
- Open Access
- 28 October 2021
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (Supplement)
EP.WE.628The Challenges of Consent and COVID-19: Analysis of Documentation of Risk of Hospital Acquired COVID-19 Infection in a District General Hospital
The COVID-19 pandemic poses a new material risk to hospital admissions and we must modify consenting practice accordingly. This study assessed documentation of the risk of COVID-19 infection and associated morbidity in consenting practice for patients undergoing general surgical procedures under general anaesthesia at a district general hospital. This is was a two-cycle study design. An initial retrospective case-note analysis of 41 inpatient consent forms and operation notes during April 2020 was performed. Data were gathered on points from the Royal College of Surgeons (RCS) guidance, including documentation of risk of COVID-19 infection. Recommendations were then offered including a teaching session from the departmental lead into the importance of documenting risk of COVID-19 infection. A prospective case-note analysis of 45 inpatient consent forms and operation notes during November to December 2020 was then performed. In cycle one, of 41 cases, 39% (16) had risk of chest infection documented. Of these, 16 (63%) specified COVID-19 in risk documentation. Morbidity related to COVID-19 was documented in 4 (25%) of these 16 cases. Following interventions, of 45 cases, 93% had risk of COVID-19 infection and associated morbidity documented (χ2 = 89.3646, p < 0.00001 significant at p < 0.05). We initially identified a deviation from RCS consent guidance. The second cycle results show a significant improvement in consenting practice for the risk of contracting COVID-19 for inpatient surgical procedures. We aim to further refine our recommendations to ensure that this material risk is communicated to patients during the initial consent process.
- 28 October 2021
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (Supplement)
Open AccessEP.WE.628The Challenges of Consent and COVID-19: Analysis of Documentation of Risk of Hospital Acquired COVID-19 Infection in a District General Hospital
The COVID-19 pandemic poses a new material risk to hospital admissions and we must modify consenting practice accordingly. This study assessed documentation of the risk of COVID-19 infection and associated morbidity in consenting practice for patients undergoing general surgical procedures under general anaesthesia at a district general hospital. This is was a two-cycle study design. An initial retrospective case-note analysis of 41 inpatient consent forms and operation notes during April 2020 was performed. Data were gathered on points from the Royal College of Surgeons (RCS) guidance, including documentation of risk of COVID-19 infection. Recommendations were then offered including a teaching session from the departmental lead into the importance of documenting risk of COVID-19 infection. A prospective case-note analysis of 45 inpatient consent forms and operation notes during November to December 2020 was then performed. In cycle one, of 41 cases, 39% (16) had risk of chest infection documented. Of these, 16 (63%) specified COVID-19 in risk documentation. Morbidity related to COVID-19 was documented in 4 (25%) of these 16 cases. Following interventions, of 45 cases, 93% had risk of COVID-19 infection and associated morbidity documented (χ2 = 89.3646, p < 0.00001 significant at p < 0.05). We initially identified a deviation from RCS consent guidance. The second cycle results show a significant improvement in consenting practice for the risk of contracting COVID-19 for inpatient surgical procedures. We aim to further refine our recommendations to ensure that this material risk is communicated to patients during the initial consent process.